VE1 immunohistochemistry predicts BRAF V600E mutation status and clinical outcome in colorectal cancer

AIM: VE1 is a monoclonal antibody detecting mutant BRAF(V600E) protein by immunohistochemistry. Here we aim to determine the inter-observer agreement and concordance of VE1 with mutational status, investigate heterogeneity in colorectal cancers and metastases and determine the prognostic effect of V...

Descripción completa

Detalles Bibliográficos
Autores principales: Schafroth, Christian, Galván, José A., Centeno, Irene, Koelzer, Viktor H., Dawson, Heather E., Sokol, Lena, Rieger, Gregor, Berger, Martin D., Hädrich, Marion, Rosenberg, Robert, Nitsche, Ulrich, Schnüriger, Beat, Langer, Rupert, Inderbitzin, Daniel, Lugli, Alessandro, Zlobec, Inti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper: Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747166/
https://www.ncbi.nlm.nih.gov/pubmed/26496026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747166/
https://www.ncbi.nlm.nih.gov/pubmed/26496026

Ejemplares similares